EXAGEN INC. (XGN) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 517.00K USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 22.32M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 51.94M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $517.00K | $22.32M | (m) | (m) | $51.94M | (m) |
| 2026-03-31 | (m) | (m) | $580.00K | $22.29M | (m) | (m) | $51.96M | (m) |
| 2025-12-31 | (m) | (m) | $643.00K | $22.26M | (m) | (m) | $58.02M | (m) |
| 2025-09-30 | (m) | (m) | $680.00K | $22.26M | (m) | (m) | $62.82M | (m) |
| 2025-06-30 | (m) | (m) | $667.00K | $22.31M | (m) | (m) | $58.76M | (m) |
| 2025-03-31 | (m) | (m) | $2.54M | $18.41M | (m) | (m) | $40.29M | (m) |
| 2024-12-31 | (m) | (m) | $423.00K | $19.82M | (m) | (m) | $44.69M | (m) |
| 2024-09-30 | (m) | (m) | $430.00K | $19.82M | (m) | (m) | $43.60M | (m) |
| 2024-06-30 | (m) | (m) | $423.00K | $19.83M | (m) | (m) | $49.31M | (m) |
| 2024-03-31 | (m) | (m) | $268.00K | $19.27M | (m) | (m) | $50.81M | (m) |
| 2023-12-31 | (m) | (m) | $264.00K | $19.23M | (m) | (m) | $56.94M | (m) |
| 2023-09-30 | (m) | (m) | $261.00K | $19.19M | (m) | (m) | $60.93M | (m) |
| 2023-06-30 | (m) | (m) | $257.00K | $19.15M | (m) | (m) | $64.18M | (m) |
| 2023-03-31 | (m) | (m) | $254.00K | $29.09M | (m) | (m) | $79.23M | (m) |
| 2022-12-31 | (m) | (m) | $190.00K | $28.78M | (m) | (m) | $86.22M | (m) |
| 2022-09-30 | (m) | (m) | (m) | $28.01M | (m) | (m) | $101.60M | (m) |
| 2022-06-30 | (m) | (m) | (m) | $27.83M | (m) | (m) | $107.72M | (m) |
| 2022-03-31 | (m) | (m) | (m) | $27.65M | (m) | (m) | $122.04M | (m) |
| 2021-12-31 | (m) | (m) | (m) | $27.48M | (m) | (m) | $123.44M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $27.29M | (m) | (m) | $127.77M | (m) |
| 2021-06-30 | (m) | (m) | (m) | $27.07M | (m) | (m) | $133.32M | (m) |
| 2021-03-31 | (m) | (m) | (m) | $26.86M | (m) | (m) | $137.52M | (m) |
| 2020-12-31 | (m) | (m) | (m) | $26.66M | (m) | (m) | $78.38M | (m) |
| 2020-09-30 | (m) | (m) | (m) | $26.45M | (m) | (m) | $79.99M | (m) |
| 2020-06-30 | (m) | (m) | (m) | $26.25M | (m) | (m) | $80.51M | (m) |
| 2020-03-31 | (m) | (m) | (m) | $26.05M | (m) | (m) | $84.64M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $25.85M | (m) | (m) | $88.31M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $25.68M | (m) | (m) | $92.74M | (m) |
| 2018-12-31 | (m) | (m) | (m) | $24.62M | (m) | (m) | $28.89M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |